Literature DB >> 30683243

Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment.

Wanqing Chen1, Changfa Xia2, Rongshou Zheng2, Maigeng Zhou3, Chunqing Lin4, Hongmei Zeng2, Siwei Zhang2, Lijun Wang3, Zhixun Yang2, Kexin Sun2, He Li2, Matthew D Brown5, Farhad Islami6, Freddie Bray7, Ahmedin Jemal6, Jie He8.   

Abstract

BACKGROUND: Understanding disparities in the burden of cancer attributable to different risk factors is crucial to inform and improve cancer prevention and control. In this report, we estimate the site-specific population-attributable fractions (PAFs) for 23 potentially modifiable risk factors across all provinces in China.
METHODS: In this comparative risk assessment study, we used 2014 cancer mortality data for adults from 978 county-level surveillance points in 31 provinces of mainland China. Risk-factor prevalence estimates were obtained from representative surveys. We used summary relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses of studies in China. We calculated PAFs using multiple formulae incorporating exposure prevalence and relative risk data stratified by age, sex and province and then combined to create summary PAFs by sex, cancer site, and risk factors.
FINDINGS: About 1 036 004 cancer deaths (45·2% of all cancer deaths [95% CI 44·0-46·4]) in China in 2014 in adults aged 20 years or older were attributable to 23 evaluated risk factors. The PAF was higher in men (51·2% [95% CI 50·0-52·4]) than in women (34·9% [33·6-36·2]), with the leading risk factors being active smoking in men and low fruit intake in women. By province, the PAF in both sexes combined ranged from 35·2% in Shanghai to 52·9% in Heilongjiang, while the PAF varied from 40·9% in Shanghai to 56·4% in Guangdong among men and from 26·9% in Shanghai to 48·0% in Heilongjiang among women. The highest PAF among men was smoking in all 31 provinces, whereas among women it varied among low fruit intake (14 provinces), hepatitis B virus infection (seven provinces), smoking (six provinces), excess bodyweight (three provinces), and human papilloma virus infection (one province).
INTERPRETATION: The PAFs of cancers attributable to potentially modifiable risk factors vary substantially across provinces in China. Regional adoption of effective primary cancer prevention strategies has a vast potential to reduce the burden of cancer and disparities in China. Smoking, poor diet, and infection warrant particular policy attention as they contributed a large proportion to the total cancer burden. FUNDING: National Science and Technology Basic Research Special Foundation of China.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30683243     DOI: 10.1016/S2214-109X(18)30488-1

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  52 in total

1.  Thyroid cancer: incidence and mortality trends in China, 2005-2015.

Authors:  Junyi Wang; Fangfang Yu; Yanna Shang; Zhiguang Ping; Li Liu
Journal:  Endocrine       Date:  2020-01-30       Impact factor: 3.633

2.  Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model.

Authors:  Maomao Cao; He Li; Dianqin Sun; Lin Lei; Jiansong Ren; Jufang Shi; Ni Li; Ji Peng; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

3.  Attributable deaths of liver cancer in China.

Authors:  Maomao Cao; Chao Ding; Changfa Xia; He Li; Dianqin Sun; Siyi He; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2021-08-31       Impact factor: 5.087

4.  Trends of cancer mortality in Xi'an City, China: 2005-2020.

Authors:  Ning Chen; Xiao-Yu Zhang; Lin-Lin Ma; Guo-Dong Zhao; Yu-Xiang Yan
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-14       Impact factor: 4.322

5.  Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma.

Authors:  Jing-Yu Hou; Ya-Ting Xiao; Jing-Bo Huang; Xin-Hua Jiang; Kai Jiang; Xun Li; Li Xu; Min-Shan Chen
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

6.  Association of cancer prevention awareness with esophageal cancer screening participation rates: Results from a population-based cancer screening program in rural China.

Authors:  Shangchun Jia; He Li; Hongmei Zeng; Rongshou Zheng; Jiang Li; Jufang Shi; Zhixun Yang; Maomao Cao; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2019-08       Impact factor: 5.087

7.  Screening and potential role of tRFs and tiRNAs derived from tRNAs in the carcinogenesis and development of lung adenocarcinoma.

Authors:  Jinhua Zhang; Linhui Li; Lilin Luo; Xuantao Yang; Juanjuan Zhang; Yuxin Xie; Rui Liang; Wanpu Wang; Shuaiyao Lu
Journal:  Oncol Lett       Date:  2021-05-02       Impact factor: 2.967

Review 8.  Tobacco and the lung cancer epidemic in China.

Authors:  Mark Parascandola; Lin Xiao
Journal:  Transl Lung Cancer Res       Date:  2019-05

9.  Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States.

Authors:  Shao-Ming Wang; Hormuzd A Katki; Barry I Graubard; Lisa L Kahle; Anil Chaturvedi; Charles E Matthews; Neal D Freedman; Christian C Abnet
Journal:  Am J Gastroenterol       Date:  2021-09-01       Impact factor: 12.045

10.  HOXA9 Expression is Associated with Advanced Tumour Stage and Prognosis in Nasopharyngeal Carcinoma.

Authors:  Tiancong Liu; Chao Ji; Yang Sun; Weiliang Bai
Journal:  Cancer Manag Res       Date:  2021-05-21       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.